Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Insmed reported $2.64B in Market Capitalization this June of 2023, considering the latest stock price and the number of outstanding shares.

Market Capitalization Change
Alimera Sciences ALIM:US USD 15M 4M
BioMarin Pharmaceutical BMRN:US USD 18.24B 992M
Cytokinetics CYTK:US USD 3.36B 972M
DBV Technologies DBVT:US USD 328M 11M
Dynavax Technologies DVAX:US USD 1.25B 105M
Gilead Sciences GILD:US USD 103.55B 4.13B
Heron Therapeutics HRTX:US USD 180M 117M
Insmed INSM:US USD 2.33B 381M
Iveric bio Inc. OPHT:US USD 3.34B 426M
Mirati Therapeutics MRTX:US USD 2.16B 449M
Novartis NVS:US USD 208.53B 8.83B
Regeneron Pharmaceuticals REGN:US USD 89.83B 11.26B
Sarepta Therapeutics SRPT:US USD 12.84B 1.46B
Seattle Genetics SGEN:US USD 37.89B 14.02B
Ultragenyx Pharmaceutical RARE:US USD 2.82B 432M
Vertex Pharmaceuticals VRTX:US USD 81.16B 7.03B